Akso Health Group (AHG)
NASDAQ: AHG · Real-Time Price · USD
0.7513
+0.0013 (0.17%)
At close: Sep 18, 2026, 4:00 PM EDT
0.7400
-0.0113 (-1.50%)
After-hours: Sep 18, 2026, 7:05 PM EDT

Akso Health Group Ratios and Metrics

Millions USD. Fiscal year is Apr - Mar.

Total Valuation

Fiscal Quarter
CurrentH2 2026H1 2026H2 2025H1 2025H2 2024H1 2024H2 2023H1 2023H2 2022H1 2022
Period Ending
Sep '26 Mar '26 Sep '25 Mar '25 Sep '24 Mar '24 Sep '23 Mar '23 Sep '22 Mar '22 Sep '21
6441,953955425178170248213936
Market Cap Growth (YoY)
-34.84%359.39%435.95%150.55%633.49%1990.59%17.04%-78.99%-43.11%28.42%52.37%
Enterprise Value
6461,94478134195171268173534
Last Close Price
0.752.281.731.181.071.161.040.350.911.692.24

Price Ratios

Fiscal Quarter
CurrentH2 2026H1 2026H2 2025H1 2025H2 2024H1 2024H2 2023H1 2023H2 2022H1 2022
Period Ending
Sep '26 Mar '26 Sep '25 Mar '25 Sep '24 Mar '24 Sep '23 Mar '23 Sep '22 Mar '22 Sep '21
PE Ratio
--------25.61--
Forward PE
-5.085.085.085.085.085.085.085.085.085.08
PS Ratio
46.53141.2264.3228.7721.0770.2910.950.621.75-56.32
PB Ratio
3.5610.804.812.130.891.234.560.922.093.151.87
P/TBV Ratio
3.5610.805.292.362.021.234.650.932.093.151.87
P/FCF Ratio
--152.68-415.76-125.59-14.48----
P/OCF Ratio
--131.57361.20-125.59-14.48---44.23
PEG Ratio
-0.510.510.510.510.510.510.510.510.510.51

EV Ratios

Fiscal Quarter
CurrentH2 2026H1 2026H2 2025H1 2025H2 2024H1 2024H2 2023H1 2023H2 2022H1 2022
Period Ending
Sep '26 Mar '26 Sep '25 Mar '25 Sep '24 Mar '24 Sep '23 Mar '23 Sep '22 Mar '22 Sep '21
EV/Sales Ratio
46.69140.5652.5923.0511.2470.6511.800.591.46-52.99
EV/FCF Ratio
--151.98-333.10-126.24-15.60----

Financial Efficiency

Fiscal Quarter
CurrentH2 2026H1 2026H2 2025H1 2025H2 2024H1 2024H2 2023H1 2023H2 2022H1 2022
Period Ending
Sep '26 Mar '26 Sep '25 Mar '25 Sep '24 Mar '24 Sep '23 Mar '23 Sep '22 Mar '22 Sep '21
Debt / Equity Ratio
0.010.010.010.010.030.011.881.100.983.030.61
Debt / FCF Ratio
--0.19-2.04-1.48-5.98----
Net Debt / Equity Ratio
0.010.01-0.05-0.87-0.42-0.600.140.20-0.031.53-0.18
Net Debt / EBITDA Ratio
-1.35-1.356.2098.21161.55---0.121.48-0.17
Net Debt / FCF Ratio
-0.17-0.170.05-170.2821.88-61.55-0.46-0.540.23-0.37
Return on Capital Employed (ROCE)
-2.20%-2.20%-2.40%-2.00%-3.40%-6.20%-306.90%-161.40%-2.20%--99.90%

Yields

Fiscal Quarter
CurrentH2 2026H1 2026H2 2025H1 2025H2 2024H1 2024H2 2023H1 2023H2 2022H1 2022
Period Ending
Sep '26 Mar '26 Sep '25 Mar '25 Sep '24 Mar '24 Sep '23 Mar '23 Sep '22 Mar '22 Sep '21
Earnings Yield
-2.90%-0.96%-14.21%-31.75%-3.70%-5.57%-23.17%-16.75%3.91%--55.26%
FCF Yield
-1.99%-0.66%-17.64%0.24%-2.17%0.80%-6.91%-40.08%-6.43%--25.57%
Buyback Yield / Dilution
-153.50%-153.97%-152.81%-371.72%-919.05%-212.60%---35.37%--3.61%
SEC Filings: 10-K · 10-Q